Corona Remedies Ltd. IPO logo

Corona Remedies Ltd. IPO Details – Price, Date, GMP & Analysis

Upcoming
Mainboard
Price Range:
Rs.1008.00 to 1062.00
Issue Size:
Rs.655.37 Cr
Lot Size:
14 shares
Open Date:
December 8

Corona Remedies Ltd. IPO Overview

Bidding Dates
December 8 - December 10
Min Investment
₹14,112
Price Range
₹1008.00 to 1062.00
Issue Size
655.37 Cr
IPO DRHP Doc
Not Available

Company Overview

Corona Remedies Limited, established in August 2004, is a pharmaceutical company focused on women's healthcare, cardiology, pain management, urology, and other therapeutic areas. The company offers a diverse portfolio of 71 brands and has a pan-India marketing network with 2,671 medical representatives across 22 states. It operates two manufacturing facilities in Gujarat with a capacity of 1,285.44 million units per annum.

IPO Timeline

Timeline information will be updated when available.

Latest Subscription Data

CategorySubscriptionStatus
QIB (Qualified Institutional Buyers)293.80xOversubscribed
NII (Non-Institutional Investors/HNI)220.18xOversubscribed
RII (Retail Individual Investors)30.39xOversubscribed
Total Subscription144.54xOversubscribed

Last updated: Dec 10, 2025, 06:21 PM

Current GMP:
Rs.342.5
Est. Listing:
Rs.342.5
Est. Gain:
+32.3%
Star Rating:
(0/5)

Financial Information

Financial information will be available when the company releases its DRHP.

Strengths & Risks Analysis

Key Strengths

Competitive advantages and positive aspects

  • Consistent revenue growth with a CAGR of approximately 21% over the last three years.
  • Diversified product portfolio across multiple therapeutic areas.
  • Strong distribution network with a presence in urban and semi-urban areas.
  • Leadership positions in specific therapeutic segments, such as women’s healthcare and pain management.
  • EU-GMP and WHO-certified manufacturing facilities ensure high-quality production standards

IPO Details

Detailed information will be available closer to the IPO launch date.